Bołkun, Ł.; Starosz, A.; Krętowska-Grunwald, A.; Wasiluk, T.; Walewska, A.; Wierzbowska, A.; Moniuszko, M.; Grubczak, K.
Effects of Combinatory In Vitro Treatment with Immune Checkpoint Inhibitors and Cytarabine on the Anti-Cancer Immune Microenvironment in De Novo AML Patients. Cancers 2024, 16, 462.
https://doi.org/10.3390/cancers16020462
AMA Style
Bołkun Ł, Starosz A, Krętowska-Grunwald A, Wasiluk T, Walewska A, Wierzbowska A, Moniuszko M, Grubczak K.
Effects of Combinatory In Vitro Treatment with Immune Checkpoint Inhibitors and Cytarabine on the Anti-Cancer Immune Microenvironment in De Novo AML Patients. Cancers. 2024; 16(2):462.
https://doi.org/10.3390/cancers16020462
Chicago/Turabian Style
Bołkun, Łukasz, Aleksandra Starosz, Anna Krętowska-Grunwald, Tomasz Wasiluk, Alicja Walewska, Agnieszka Wierzbowska, Marcin Moniuszko, and Kamil Grubczak.
2024. "Effects of Combinatory In Vitro Treatment with Immune Checkpoint Inhibitors and Cytarabine on the Anti-Cancer Immune Microenvironment in De Novo AML Patients" Cancers 16, no. 2: 462.
https://doi.org/10.3390/cancers16020462
APA Style
Bołkun, Ł., Starosz, A., Krętowska-Grunwald, A., Wasiluk, T., Walewska, A., Wierzbowska, A., Moniuszko, M., & Grubczak, K.
(2024). Effects of Combinatory In Vitro Treatment with Immune Checkpoint Inhibitors and Cytarabine on the Anti-Cancer Immune Microenvironment in De Novo AML Patients. Cancers, 16(2), 462.
https://doi.org/10.3390/cancers16020462
